LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article ; Online: Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.

    Violi, Francesco / Ceccarelli, Giancarlo / Cangemi, Roberto / Cipollone, Francesco / D'Ardes, Damiano / Oliva, Alessandra / Pirro, Matteo / Rocco, Monica / Alessandri, Francesco / D'Ettorre, Gabriella / Lichtner, Miriam / Pignatelli, Pasquale / Ferro, Domenico / Ruberto, Franco / Lip, Gregory Y H / Pugliese, Francesco / Mastroianni, Claudio Maria

    Internal and emergency medicine

    2021  Volume 16, Issue 5, Page(s) 1231–1237

    Abstract: Background: Patients with coronavirus disease 2019 (Covid-19) may experience venous thrombosis ... predicted morality.: Conclusions: Covid-19 patients experience an equipollent rate of venous and arterial ... and 75 (20%) died. Thrombotic events included 41 venous thromboembolism and 34 arterial thrombosis ...

    Abstract Background: Patients with coronavirus disease 2019 (Covid-19) may experience venous thrombosis while data regarding arterial thrombosis are sparse.
    Methods: Prospective multicenter study in 5 hospitals including 373 patients with Covid-19-related pneumonia. Demographic data, laboratory findings including coagulation tests and comorbidities were reported. During the follow-up any arterial or venous thrombotic events and death were registered.
    Results: Among 373 patients, 75 (20%) had a thrombotic event and 75 (20%) died. Thrombotic events included 41 venous thromboembolism and 34 arterial thrombosis. Age, cardiovascular disease, intensive care unit treatment, white blood cells, D-dimer, albumin and troponin blood levels were associated with thrombotic events. In a multivariable regression logistic model, intensive care unit treatment (Odds Ratio [OR]: 6.0; 95% Confidence Interval [CI] 2.8-12.6; p < 0.001); coronary artery disease (OR: 2.4; 95% CI 1.4-5.0; p = 0.022); and albumin levels (OR: 0.49; 95% CI 0.28-0.87; p = 0.014) were associated with ischemic events. Age, sex, chronic obstructive pulmonary disease, diabetes, heart failure, coronary heart disease, intensive care unit treatment, in-hospital thrombotic events, D-dimer, C-reactive protein, troponin, and albumin levels were associated with mortality. A multivariable Cox regression analysis showed that in-hospital thrombotic events (hazard ratio [HR]: 2.72; 95% CI 1.59-4.65; p < 0.001), age (HR: 1.035; 95% CI 1.014-1.057; p = 0.001), and albumin (HR: 0.447; 95% CI 0.277-0.723; p = 0.001) predicted morality.
    Conclusions: Covid-19 patients experience an equipollent rate of venous and arterial thrombotic events, that are associated with poor survival. Early identification and appropriate treatment of Covid-19 patients at risk of thrombosis may improve prognosis.
    MeSH term(s) Aged ; Aged, 80 and over ; C-Reactive Protein/analysis ; COVID-19/complications ; COVID-19/epidemiology ; Coronary Artery Disease/epidemiology ; Coronary Artery Disease/etiology ; Female ; Fibrin Fibrinogen Degradation Products/analysis ; Humans ; Intensive Care Units/organization & administration ; Intensive Care Units/statistics & numerical data ; Kaplan-Meier Estimate ; Logistic Models ; Male ; Middle Aged ; Mortality/trends ; Odds Ratio ; Proportional Hazards Models ; Prospective Studies ; Thromboembolism/epidemiology ; Thromboembolism/etiology
    Chemical Substances Fibrin Fibrinogen Degradation Products ; fibrin fragment D ; C-Reactive Protein (9007-41-4)
    Language English
    Publishing date 2021-07-04
    Publishing country Italy
    Document type Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 2454173-4
    ISSN 1970-9366 ; 1828-0447
    ISSN (online) 1970-9366
    ISSN 1828-0447
    DOI 10.1007/s11739-020-02621-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Venous and arterial thrombosis in COVID-19

    Zainab Al Duhailib / Simon Oczkowski / Kamil Polok / Jakub Fronczek / Wojciech Szczeklik / Joshua Piticaru / Manoj J. Mammen / Fayez Alshamsi / John Eikelboom / Emilie Belley-Cote / Waleed Alhazzani

    Journal of Infection and Public Health, Vol 15, Iss 6, Pp 689-

    An updated narrative review

    2022  Volume 702

    Abstract: Hospitalized patients with coronavirus disease 2019 (COVID-19), particularly those admitted ... While existing evidence is limited in quality, COVID-19 appears to increase micro-and macro-vascular thrombosis ... hemostatic derangements and thrombotic complications in patients with COVID-19. The aim of this review ...

    Abstract Hospitalized patients with coronavirus disease 2019 (COVID-19), particularly those admitted to the intensive care unit (ICU) are at high risk of morbidity and mortality. Several observational studies have described hemostatic derangements and thrombotic complications in patients with COVID-19. The aim of this review article is to summarize the current evidence on pathologic findings, pathophysiology, coagulation and hemostatic abnormalities, D-dimer’s role in prognostication epidemiology and risk factors of thrombotic complications, and the role of prophylactic and therapeutic anticoagulation in patients with COVID-19. While existing evidence is limited in quality, COVID-19 appears to increase micro-and macro-vascular thrombosis rates in hospitalized and critically ill patients, which may contribute to the burden of disease. D-dimer can be used for risk stratification of hospitalized patients, but its role to guide anticoagulation therapy remains unclear. Evidence of higher quality is needed to address the role of therapeutic anticoagulation or high-intensity venous thromboembolism prophylaxis in COVID-19 patients. Take-home points: • The prevalence of venous thromboembolism (VTE) in hospitalized COVID-19 patients is high, therefore, clinicians should have a high index of suspicion. • The pathophysiology of thrombosis is likely related to a combination of SARS-CoV-2 direct endothelial injury and dysregulated inflammation causing coagulation activation. • The current evidence on the value of D-dimer guided therapy is limited. • The rate of VTE post-hospital discharge is very low, supporting the safety of current discharge practice without VTE prophylaxis in most patients. • The role of higher-intensity VTE prophylaxis or therapeutic anticoagulation in critically ill COVID-19 patients without documented or suspected VTE remains uncertain. • Therapeutic anticoagulation in hospitalized non-critically ill patients with COVID-19 may improve outcomes but more research is warranted.
    Keywords Anticoagulation ; COVID-19 ; Thrombosis ; Venous thromboembolism prophylaxis ; Critically ill ; D-dimer level ; Infectious and parasitic diseases ; RC109-216 ; Public aspects of medicine ; RA1-1270
    Subject code 610
    Language English
    Publishing date 2022-06-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article: An extensive arterial thrombosis with lower limb ischemia in a COVID-19 patient: A case report.

    Andriamizanaka, Johary Andriamamonjisoa / Rakotomijoro, Etienne / Andriananja, Volatiana / Raberahona, Mihaja / Andrianasolo, Radonirina Lazasoa / Rakotoarivelo, Rivonirina Andry / de Dieu Randria Mamy, Jean

    Clinical case reports

    2023  Volume 11, Issue 11, Page(s) e8231

    Abstract: The coronavirus disease 2019 (COVID-19) pandemic is responsible for huge morbidity and mortality ... with high morbidity and mortality. Arterial thrombosis in COVID-19 is poorly described compared ... which may lead to venous and arterial thromboembolic diseases. This hypercoagulability state is also associated ...

    Abstract The coronavirus disease 2019 (COVID-19) pandemic is responsible for huge morbidity and mortality throughout the world. Several serious complications of this disease have been reported. It can cause hypercoagulability, which may lead to venous and arterial thromboembolic diseases. This hypercoagulability state is also associated with high morbidity and mortality. Arterial thrombosis in COVID-19 is poorly described compared to venous thrombosis and pulmonary embolism. We report a case of an extensive arterial thrombosis leading to a limb ischemia with extremely high D-dimer in a COVID-19 patient. A 69-year-old man was hospitalized for febrile dyspnea. He is a hypertensive and diabetic patient. On admission, pulse oxygen saturation was 72% on room air. He had cyanosis of the left foot up to the mid-thigh. The left pedal, posterior tibial, popliteal and femoral pulses were abolished. Chest CT scan was in favor of COVID-19. He has a high D-dimer level of 257,344 ng/mL. Arterial Echo-Doppler found an extensive intraluminal thrombus along the arterial axes of the left lower limb, completely obstructing them, starting from the primitive iliac artery just after its bifurcation with the aorta, and extending distally (external iliac; common femoral; superficial femoral; popliteal; anterior tibial; posterior tibial; fibular and pedal). The patient was diagnosed with COVID-19 critical form, associated with ischemia of the left lower limb secondary to an extensive arterial thrombosis. He was receiving anticoagulation, and underwent surgical amputation of the ischemic limb. The patient survived the event; however, he was on long-term oxygen therapy at home. Arterial thrombosis may occur during COVID-19 and may be responsible for peripheral or central ischemia aggravating morbidity and mortality. The occurrence of these events is related to the D-dimer value. Anticoagulation is an important part of the management of COVID-19, especially in severe forms in order to limit the occurrence of these thromboembolic diseases.
    Language English
    Publishing date 2023-11-20
    Publishing country England
    Document type Case Reports
    ZDB-ID 2740234-4
    ISSN 2050-0904
    ISSN 2050-0904
    DOI 10.1002/ccr3.8231
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: How Should Concurrent Arterial and Venous Thrombosis Associated With SARS-CoV-2 Infection Be Managed?

    Dimosiari, Athina / Patoulias, Dimitrios / Michailidis, Theodoros / Dimitroulas, Theodoros

    European journal of case reports in internal medicine

    2022  Volume 9, Issue 5, Page(s) 3366

    Abstract: ... with both arterial and venous thrombotic events, which increase morbidity and mortality.Concurrent arterial and ... and the venous systems. However, concurrent arterial and venous thrombosis is extremely rare. Herein ... Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 ...

    Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), is associated with a high incidence of thrombotic complications involving both the arterial and the venous systems. However, concurrent arterial and venous thrombosis is extremely rare. Herein, we present the case of a 75-year-old male patient with severe COVID-19 who developed bilateral renal artery thrombosis and pulmonary embolism during the disease course. To our knowledge, this is the first such case described in the literature.
    Learning points: SARS-CoV-2-related coagulopathy is associated with both arterial and venous thrombotic events, which increase morbidity and mortality.Concurrent arterial and venous thrombotic events attributed to SARS-CoV-2 are extremely rare.A high index of clinical suspicion is required, while further research is needed to determine the optimal type, dose and duration of anticoagulation in such cases.
    Language English
    Publishing date 2022-05-17
    Publishing country Italy
    Document type Journal Article
    ISSN 2284-2594
    ISSN (online) 2284-2594
    DOI 10.12890/2022_003366
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Acute arterial and deep venous thromboembolism in COVID-19 patients: Risk factors and personalized therapy.

    Bozzani, Antonio / Arici, Vittorio / Tavazzi, Guido / Franciscone, Mila Maria / Danesino, Vittorio / Rota, Monica / Rossini, Rosa / Sterpetti, Antonio V / Ticozzelli, Giulia / Rumi, Elisa / Mojoli, Francesco / Bruno, Raffaele / Ragni, Franco

    Surgery

    2020  Volume 168, Issue 6, Page(s) 987–992

    Abstract: ... related to coronavirus disease 2019 infection, with a mortality rate of 181/100,000 inhabitants and ... with severe coronavirus disease 2019 infection (6 with lower limb arterial thrombosis and 32 ... 2019 patients who develop arterial and deep vein thrombosis have a high risk of mortality ...

    Abstract Background: The Lombardy region suffered severely during the acute phase of the coronavirus disease 2019 outbreak in Italy (Mar-Apr 2020) with 16,000 diagnosed coronavirus disease 2019-related deaths (49% of the total coronavirus disease 2019-related deaths in Italy). In the area surrounding Pavia during the critical stage of the outbreak (Mar-Apr 2020), 1,225 of the documented 4,200 deaths were related to coronavirus disease 2019 infection, with a mortality rate of 181/100,000 inhabitants and an increase in deaths of 138% compared with the same period during previous years. Our aim was to report the experience of the Department of Vascular Surgery of Pavia (Lombardy, Italy), including the lessons learned and future perspectives regarding the management of coronavirus disease 2019 patients who developed severe acute ischemia with impending lower limb loss or deep vein thrombosis.
    Materials and methods: We carried out a retrospective data collection of coronavirus disease 2019 patients with severe acute ischemia of the lower limbs or deep vein thrombosis, which we observed in our department during the period March 1, 2020, to April 30, 2020. Primary outcomes of the analysis were postoperative mortality for all patients and amputation rates only in those coronavirus disease 2019 patients suffering from acute lower limb ischemia. Secondary outcomes were the prevalence of the disease among admitted coronavirus disease 2019 patients, and any possible correlation among inflammatory parameters, thrombolytic status, and the presence of acute ischemia or deep vein thrombosis.
    Results: We observed 38 patients (28 male) with severe coronavirus disease 2019 infection (6 with lower limb arterial thrombosis and 32 with deep vein thrombosis). The median patient age was 64 years (range 30-94 y). In the arterial group, 3 had thrombosis on plaque and 3 on healthy arteries ("simple" arterial thrombosis). All underwent operative or hybrid (open/endo) revascularization; 1 patient died from major organ failure and 1 patient underwent major amputation. In the deep vein thrombosis group, 9 (28%) patients died from major organ failure, despite aggressive medical therapy. In patients with simple arterial thrombosis and those with deep vein thrombosis, we observed a decrease in inflammatory parameters (C-reactive protein) and in D-dimer and fibrinogen after aggressive therapy (P <.001).
    Conclusion: Our study confirms that critically ill, coronavirus disease 2019 patients who develop arterial and deep vein thrombosis have a high risk of mortality, but, if treated properly, there is an improvement in overall survival, especially in patients of 60 years of age or younger.
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; Arteries ; COVID-19/complications ; COVID-19/epidemiology ; Female ; Follow-Up Studies ; Humans ; Italy/epidemiology ; Male ; Middle Aged ; Pandemics ; Precision Medicine/methods ; Retrospective Studies ; Risk Assessment/methods ; Risk Factors ; SARS-CoV-2 ; Thrombosis/epidemiology ; Thrombosis/etiology ; Vascular Surgical Procedures ; Venous Thromboembolism/epidemiology ; Venous Thromboembolism/etiology
    Keywords covid19
    Language English
    Publishing date 2020-09-22
    Publishing country United States
    Document type Journal Article
    ZDB-ID 202467-6
    ISSN 1532-7361 ; 0039-6060
    ISSN (online) 1532-7361
    ISSN 0039-6060
    DOI 10.1016/j.surg.2020.09.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Acute arterial and deep venous thromboembolism in COVID-19 patients. Risk factors and personalized therapy

    Bozzani, Antonio / Arici, Vittorio / Tavazzi, Guido / Franciscone, Mila Maria / Danesino, Vittorio / Rota, Monica / Rossini, Rosa / Sterpetti, Antonio V / Ticozzelli, Giulia / Rumi, Elisa / Mojoli, Francesco / Bruno, Raffaele / Ragni, Franco

    2020  

    Abstract: ... to coronavirus disease 2019 infection, with a mortality rate of 181/100,000 inhabitants and an increase in deaths ... outbreak in Italy (Mar-Apr 2020) with 16,000 diagnosed coronavirus disease 2019-related deaths (49 ... of the total coronavirus disease 2019-related deaths in Italy). In the area surrounding Pavia during ...

    Abstract The Lombardy region suffered severely during the acute phase of the coronavirus diease 2019 outbreak in Italy (Mar-Apr 2020) with 16,000 diagnosed coronavirus disease 2019-related deaths (49% of the total coronavirus disease 2019-related deaths in Italy). In the area surrounding Pavia during the critical stage of the outbreak (Mar-Apr 2020), 1,225 of the documented 4,200 deaths were related to coronavirus disease 2019 infection, with a mortality rate of 181/100,000 inhabitants and an increase in deaths of 138% compared with the same period during previous years. Our aim was to report the experience of the Department of Vascular Surgery of Pavia (Lombardy, Italy), including the lessons learned and future perspectives regarding the management of coronavirus disease 2019 patients who developed severe acute ischemia with impending lower limb loss or deep vein thrombosis.
    Keywords PANDEMIC ; COVID 19 ; covid19
    Subject code 610
    Language English
    Publisher Elsevier Inc.
    Publishing country it
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article: Acute arterial and deep venous thromboembolism in COVID-19 patients: Risk factors and personalized therapy

    Bozzani, Antonio / Arici, Vittorio / Tavazzi, Guido / Franciscone, Mila Maria / Danesino, Vittorio / Rota, Monica / Rossini, Rosa / Sterpetti, Antonio V / Ticozzelli, Giulia / Rumi, Elisa / Mojoli, Francesco / Bruno, Raffaele / Ragni, Franco

    Surgery (St. Louis)

    Abstract: ... to coronavirus disease 2019 infection, with a mortality rate of 181/100,000 inhabitants and an increase in deaths ... Our study confirms that critically ill, coronavirus disease 2019 patients who develop arterial and ... the prevalence of the disease among admitted coronavirus disease 2019 patients, and any possible correlation ...

    Abstract BACKGROUND: The Lombardy region suffered severely during the acute phase of the coronavirus diease 2019 outbreak in Italy (Mar-Apr 2020) with 16,000 diagnosed coronavirus disease 2019-related deaths (49% of the total coronavirus disease 2019-related deaths in Italy). In the area surrounding Pavia during the critical stage of the outbreak (Mar-Apr 2020), 1,225 of the documented 4,200 deaths were related to coronavirus disease 2019 infection, with a mortality rate of 181/100,000 inhabitants and an increase in deaths of 138% compared with the same period during previous years. Our aim was to report the experience of the Department of Vascular Surgery of Pavia (Lombardy, Italy), including the lessons learned and future perspectives regarding the management of coronavirus disease 2019 patients who developed severe acute ischemia with impending lower limb loss or deep vein thrombosis. MATERIALS AND METHODS: We carried out a retrospective data collection of coronavirus disease 2019 patients with severe acute ischemia of the lower limbs or deep vein thrombosis, which we observed in our department during the period March 1, 2020, to April 30, 2020. Primary outcomes of the analysis were postoperative mortality for all patients and amputation rates only in those coronavirus disease 2019 patients suffering from acute lower limb ischemia. Secondary outcomes were the prevalence of the disease among admitted coronavirus disease 2019 patients, and any possible correlation among inflammatory parameters, thrombolytic status, and the presence of acute ischemia or deep vein thrombosis. RESULTS: We observed 38 patients (28 male) with severe coronavirus disease 2019 infection (6 with lower limb arterial thrombosis and 32 with deep vein thrombosis). The median patient age was 64 years (range 30-94 y). In the arterial group, 3 had thrombosis on plaque and 3 on healthy arteries ("simple" arterial thrombosis). All underwent operative or hybrid (open/endo) revascularization; 1 patient died from major organ failure and 1 patient underwent major amputation. In the deep vein thrombosis group, 9 (28%) patients died from major organ failure, despite aggressive medical therapy. In patients with simple arterial thrombosis and those with deep vein thrombosis, we observed a decrease in inflammatory parameters (C-reactive protein) and in D-dimer and fibrinogen after aggressive therapy (P <.001). CONCLUSION: Our study confirms that critically ill, coronavirus disease 2019 patients who develop arterial and deep vein thrombosis have a high risk of mortality, but, if treated properly, there is an improvement in overall survival, especially in patients of 60 years of age or younger.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #843240
    Database COVID19

    Kategorien

To top